Los Angeles, CA, United States of America

Sherie L Morrison

USPTO Granted Patents = 23 (Patent Applications = 3)

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 2.8

ph-index = 10

Forward Citations = 777(Granted Patents)

Company Filing History:

18 out of 15,462

University of California

Qwixel Therapeutics LLC

Origen Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 1997-2025

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12415843 - Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for the treatment of cancer (2025-09-16),

2. 11795198 - Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof (2023-10-24),

3. 11136353 - Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof (2021-10-05),

4. 10975158 - CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities (2021-04-13),

5. 10822427 - Anti-CSPG4 fusions with interferon for the treatment of malignancy (2020-11-03),

6. 10182984 - Targeted interferons demonstrate potent apoptotic and anti-tumor activities (2019-01-22),

7. 10093745 - Anti-CSPG4 fusions with interferon for the treatment of malignancy (2018-10-09),

8. 9803021 - CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities (2017-10-31),

9. 9611313 - Antibody-endostatin fusion protein and its variants (2017-04-04),

10. 9534033 - Targeted interferons demonstrating potent apoptotic and anti-tumor activities (2017-01-03),

11. 9139634 - Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities (2015-09-22),

12. 8563692 - Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities (2013-10-22),

13. 8258263 - Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities (2012-09-04),

14. 7736652 - Antibody fusion proteins: effective adjuvants of protein vaccination (2010-06-15),

15. 7238784 - Rh antibody (2007-07-03),

Title: Sherie L Morrison: Innovator in Cancer Treatment

Introduction

Sherie L Morrison is a prominent innovator based in Los Angeles, California, known for her significant contributions to the field of biotechnology and cancer treatment. With a remarkable portfolio of 22 patents, Sherie's work focuses on the development of novel therapeutic modalities designed to tackle some of the most challenging diseases.

Latest Patents

Among her latest patents is a groundbreaking fusion protein composition that includes masked type I interferons (IFNA and IFNB). This innovative approach provides methods for using these proteins in the treatment of cancer and other immunological disorders. The patents reveal that masked IFNs can be fused to monoclonal antibodies or their binding fragments, allowing for effective administration as a therapeutic modality. This inventive approach offers new avenues for treating cancer and related diseases.

Career Highlights

Sherie has had a distinguished career, having worked with esteemed organizations such as the University of California and Alkermes, Inc. Her involvement in these institutions highlights her commitment to research and development, particularly in fields impacting healthcare and medical advancements.

Collaborations

Throughout her career, Sherie has collaborated with talented individuals in her field, including notable coworkers Tzu-Hsuan Huang and Caiyun Xuan. These collaborations have undoubtedly played a role in the successful development of her patented technologies.

Conclusion

Sherie L Morrison continues to be an influential figure in the realm of cancer treatment and biotechnology. Her innovative work and patented inventions have the potential to revolutionize therapeutic approaches and improve patient outcomes in various diseases. As she forges ahead in her research endeavors, she remains a beacon of inspiration for future innovations in healthcare.

This text is generated by artificial intelligence and may not be accurate.